Philips advances women’s health ultrasound with new single-transducer solution

{
  "signal_id": "82d1717c-9005-2edb-cfbc-698aa712b2bc",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-09-03T13:03:00+00:00",
  "company": {
    "name": "Philips",
    "domain": "philips.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/09/03/3355984/0/en/philips-advances-women-s-health-ultrasound-with-new-single-transducer-solution.html",
    "title": "Philips advances women’s health ultrasound with new single-transducer solution",
    "excerpt": "September 3, 2026 FDA 510(k) cleared and CE marked, the eV14-2v combines exceptional image quality and broad clinical capabilities in one lightweight transducer, helping streamline exams, support diagnostic confidence, and improve the patient experience Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced the eV14-2v transvaginal transducer, expanding its obstetrics and gynecology ultrasound portfolio. FDA 510(k) cleared and CE marked, the eV14-2v is designed to support a broad range of gynecology and early obstetrics exams by combining image quality and broad clinical capabilities in a single lightweight transducer. The new transducer will be showcased at the 36th International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress. Across obstetrics and gynecology, clinicians care for women with diverse clinical needs, from routine gynecologic exams to early pregnancy assessments and more complex cases. Achieving the desired balance of penetration and image resolution may require switching between transducers, which can interrupt workflow and extend exam times. The eV14-2v is designed to address these challenges by providing enhanced penetration, improved resolution, and a wider field of view in a lightweight, ergonomic design. The transducer delivers a 41.7% increase in penetration, a...",
    "product": "eV14-2v transvaginal transducer",
    "summary": "Royal Philips has launched the eV14-2v transvaginal transducer, a new single-transducer solution for its obstetrics and gynecology ultrasound portfolio, which has received FDA 510(k) clearance and is CE marked.",
    "location": "Amsterdam, Netherlands",
    "planning": false,
    "image_url": "https://ml-eu.globenewswire.com/Resource/Download/bf0cb28e-b150-492a-85ae-30590d8a3de3",
    "confidence": 0.95,
    "product_data": {
      "name": "eV14-2v",
      "full_text": "the eV14-2v transvaginal transducer",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-09-03T13:03:00Z",
    "location_data": [
      {
        "city": "Amsterdam",
        "state": "North Holland",
        "region": "Western Europe",
        "country": "Netherlands",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-09-03",
    "article_sentence": "Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced the eV14-2v transvaginal transducer, expanding its obstetrics and gynecology ultrasound portfolio."
  }
}

curl https://signals.autobound.ai/v1/signals/82d1717c-9005-2edb-cfbc-698aa712b2bc \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"philips.com","limit":20}'